HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ZSTK474

phosphatidylinositol 3-kinase inhibitor; structure in first source
Also Known As:
2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine; 2-(difluoromethyl)-1-(4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl)-1H-benzimidazole
Networked: 47 relevant articles (5 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yamori, Takao: 12 articles (10/2018 - 04/2006)
2. Dan, Shingo: 8 articles (01/2021 - 01/2009)
3. Kong, Dexin: 8 articles (01/2019 - 10/2007)
4. Okamura, Mutsumi: 6 articles (10/2018 - 01/2009)
5. Yoshimi, Hisashi: 6 articles (02/2015 - 04/2006)
6. Kolekar, Sharada: 3 articles (02/2021 - 01/2015)
7. Rewcastle, Gordon W: 3 articles (02/2021 - 01/2015)
8. Shepherd, Peter R: 3 articles (02/2021 - 01/2015)
9. Isoyama, Sho: 3 articles (01/2021 - 11/2012)
10. Mori, Shigeyuki: 3 articles (01/2021 - 01/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Sarcoma (Soft Tissue Sarcoma)
3. Melanoma (Melanoma, Malignant)
4. Alveolar Rhabdomyosarcoma
5. Genetic Translocation (Chromosomal Translocation)

Related Drugs and Biologics

1. Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
2. dactolisib
3. Vemurafenib
4. RAF265
5. Antineoplastic Agents (Antineoplastics)
6. AZD-0364
7. Sirolimus (Rapamycin)
8. Proteins (Proteins, Gene)
9. Phosphatidylinositols (Phosphatidylinositol)
10. Mitogen-Activated Protein Kinase Kinases (MEKs)

Related Therapies and Procedures

1. Oral Administration
2. Therapeutics